|
Market Closed -
Deutsche Boerse AG
14:20:38 25/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 149.80 EUR | +1.97% |
|
-5.49% | +26.20% |
| 09-26 | US FDA approves Mirum's drug for rare bone disorder | RE |
| 09-22 | European Pharma Leaders Push for National Reforms to Boost Investment | DJ |
Company Valuation: Ipsen
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,621 | 8,279 | 8,912 | 9,155 | 9,770 | 11,749 | - | - |
| Change | - | 25.05% | 7.65% | 2.72% | 6.72% | 20.26% | - | - |
| Enterprise Value (EV) 1 | 6,758 | 7,894 | 8,860 | 9,020 | 9,225 | 10,411 | 9,453 | 8,655 |
| Change | - | 16.81% | 12.22% | 1.81% | 2.28% | 12.85% | -9.19% | -8.45% |
| P/E | 10.4x | 12.9x | 14x | 26.7x | 22.4x | 11.9x | 12.2x | 12.4x |
| PBR | 2.42x | - | 2.36x | 2.22x | 2.3x | 2.3x | 1.95x | 1.7x |
| PEG | - | 20.02x | -13.67x | -0.6x | 0.8x | 0x | -4.81x | -8.19x |
| Capitalization / Revenue | 2.31x | 2.74x | 2.85x | 2.69x | 2.49x | 2.57x | 2.52x | 2.42x |
| EV / Revenue | 2.36x | 2.61x | 2.83x | 2.65x | 2.35x | 2.28x | 2.03x | 1.78x |
| EV / EBITDA | 5.8x | 5.86x | 10.1x | 7.52x | 6.67x | 5.5x | 5.34x | 4.87x |
| EV / EBIT | 6.68x | 7.08x | 8.85x | 8.13x | 7.13x | 6.34x | 6.29x | 5.87x |
| EV / FCF | 8.31x | 9.02x | 12.5x | 11.6x | 8.93x | 8.07x | 7.77x | 7.04x |
| FCF Yield | 12% | 11.1% | 8.02% | 8.59% | 11.2% | 12.4% | 12.9% | 14.2% |
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.535 | 1.532 | 1.655 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 1.07% | 1.07% | 1.15% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 12.02 | 11.71 | 11.54 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 12.8% | 13.1% | 14.3% |
| Net sales 1 | 2,869 | 3,025 | 3,128 | 3,401 | 3,929 | 4,564 | 4,653 | 4,854 |
| EBITDA 1 | 1,166 | 1,348 | 881.4 | 1,200 | 1,383 | 1,892 | 1,770 | 1,775 |
| EBIT 1 | 1,011 | 1,115 | 1,001 | 1,109 | 1,294 | 1,642 | 1,503 | 1,475 |
| Net income 1 | 646.6 | 647.5 | 647.2 | 347.3 | 444.5 | 1,011 | 981.8 | 966.3 |
| Net Debt 1 | 137.8 | -384.7 | -52.9 | -134.9 | -544.5 | -1,339 | -2,296 | -3,094 |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 143.30 | 143.30 | 143.30 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 81,990 | - | - |
| Announcement Date | 11/2/22 | 9/2/23 | 8/2/24 | 13/2/25 | 12/2/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.6x | 12.18x | 24.75x | 0.59% | 1,053B | |
| 30.11x | 6.7x | 18.74x | 1.98% | 652B | |
| 33.53x | 7.84x | 16.21x | 2.59% | 468B | |
| 19.76x | 4.82x | 11.93x | 2.75% | 351B | |
| 20.25x | 5.27x | 13.08x | 3.03% | 273B | |
| 20.9x | 4.34x | 12.34x | 2.04% | 254B | |
| 25.65x | 6.7x | 11.94x | 2.48% | 220B | |
| -45.27x | 6.59x | 25.75x | 2.2% | 186B | |
| 11.33x | 4.13x | 8.58x | 4.44% | 170B | |
| Average | 16.65x | 6.51x | 15.92x | 2.46% | 403.04B | |
| Weighted average by Cap. | 24.17x | 7.86x | 18.10x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IPN Stock
- I7G Stock
- Valuation Ipsen
Select your edition
All financial news and data tailored to specific country editions
